Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

<p>Supplementary Tables S1-S5</p>

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	Karolin Heinze (16540724) (author)
Tác giả khác:	Evan S. Cairns (15025116) (author), Shelby Thornton (16540727) (author), Bronwyn Harris (16540730) (author), Katy Milne (16540733) (author), Marcel Grube (15048384) (author), Charlotte Meyer (16540736) (author), Anthony N. Karnezis (16540739) (author), Sian Fereday (15062070) (author), Dale W. Garsed (15013989) (author), Samuel C.Y. Leung (16540742) (author), Derek S. Chiu (15048474) (author), Malak Moubarak (16540745) (author), Philipp Harter (16540748) (author), Florian Heitz (15025143) (author), Jessica N. McAlpine (15025155) (author), Anna DeFazio (14952738) (author), David D.L. Bowtell (15048513) (author), Ellen L. Goode (15052532) (author), Malcolm Pike (16540751) (author), Susan J. Ramus (14932688) (author), C. Leigh Pearce (16540754) (author), Annette Staebler (15048714) (author), Martin Köbel (15013986) (author), Stefan Kommoss (15048360) (author), Aline Talhouk (11793988) (author), Brad H. Nelson (15019440) (author), Michael S. Anglesio (15025164) (author)
Được phát hành:	2025
Những chủ đề:	Cancer Tumor Biology Epidemiology Genetics of Cancer Risk & Outcome Gynecological Cancers Ovarian cancer Tumor Microenvironment
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
Bằng: Karolin Heinze (16540724)
Được phát hành: (2025)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
Bằng: Robert L. Hollis (15034814)
Được phát hành: (2025)

Supplementary Table 1 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
Bằng: Sammy Ferri-Borgogno (15307295)
Được phát hành: (2025)

Supplementary Table 2 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
Bằng: Sammy Ferri-Borgogno (15307295)
Được phát hành: (2025)

Supplementary Table 3 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
Bằng: Sammy Ferri-Borgogno (15307295)
Được phát hành: (2025)

Supplementary Table 4 from Spatial Transcriptomics Depict Ligand–Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors
Bằng: Sammy Ferri-Borgogno (15307295)
Được phát hành: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
Bằng: Kankan Cao (16437263)
Được phát hành: (2025)

Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Bằng: Cheng-Kai Wang (14963880)
Được phát hành: (2025)

Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
Bằng: Daniel S. Green (15047598)
Được phát hành: (2025)

Supplemental Table S3 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
Bằng: Yeh Wang (14964041)
Được phát hành: (2025)

Supplemental Table S4 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
Bằng: Yeh Wang (14964041)
Được phát hành: (2025)

Supplementary Table S2 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
Bằng: Arun Kanakkanthara (14937731)
Được phát hành: (2025)

Supplementary Table S3 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
Bằng: Arun Kanakkanthara (14937731)
Được phát hành: (2025)

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Bằng: Stephanie Lheureux (16797697)
Được phát hành: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Bằng: Stephanie Lheureux (16797697)
Được phát hành: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Bằng: Stephanie Lheureux (16797697)
Được phát hành: (2025)

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Bằng: Stephanie Lheureux (16797697)
Được phát hành: (2025)

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Bằng: Stephanie Lheureux (16797697)
Được phát hành: (2025)

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Bằng: Nicola S. Meagher (15048462)
Được phát hành: (2025)

Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer
Bằng: Stephanie L. Wethington (16354020)
Được phát hành: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
Bằng: Félix Blanc-Durand (15049400)
Được phát hành: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Bằng: Gwo Yaw Ho (14961416)
Được phát hành: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Bằng: Raphaël Leman (17314506)
Được phát hành: (2025)

Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Bằng: Sanna Pikkusaari (15055802)
Được phát hành: (2025)

Cannot write session to /tmp/vufind_sessions/sess_iaj55qhs3tvc7g4b4ntgo1qrtc